Protagonist Therapeutics (PTGX)
(Real Time Quote from BATS)
$24.92 USD
+0.26 (1.05%)
Updated Apr 26, 2024 01:10 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $2.51 | 0.00% |
Earnings Summary
For their last quarter, Protagonist Therapeutics (PTGX) reported earnings of $0.44 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 375.00%. Look out for PTGX's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of $2.51 per share, reflecting a year-over-year increase of 474.63%.
Earnings History
Price & Consensus
Zacks News for PTGX
Wall Street Analysts Think Protagonist Therapeutics (PTGX) Could Surge 48.38%: Read This Before Placing a Bet
PTGX: What are Zacks experts saying now?
Zacks Private Portfolio Services